Why I’m Holding On to My Bristol-Myers Squibb Shares Now That the Celgene Acquisition Has Closed

Goodbye, Celgene. Hello, Bristol-Myers Squibb(NYSE:BMY).
With Bristol-Myers Squibb’s acquisition of Celgene closing on Wednesday, one of my favorite biotech stocks is now gone. Celgene became a subsidiary of BMS and is no longer a publicly traded company on …

Click here to view the original article.